A Study of Tesetaxel Plus Capecitabine in Patients With Solid Tumors

NCT01315431 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Tesetaxel plus capecitabine

Sponsor

Genta Incorporated